Syndax Pharmaceuticals Inc (SNDX)
18.94
-0.04
(-0.21%)
USD |
NASDAQ |
Nov 04, 16:00
18.50
-0.44
(-2.32%)
After-Hours: 20:00
Syndax Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Incyte Corp | 92.44% |
| Trevena Inc | 68.31% |
| Bristol-Myers Squibb Co | 75.13% |
| Arcus Biosciences Inc | -- |
| NovaBay Pharmaceuticals Inc | 66.33% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -58.96% |
| Return on Assets | -53.60% |
| Return on Invested Capital | -58.96% |
| Profit Margin (Quarterly) | -1.94K% |
| Operating Margin (Quarterly) | -2.12K% |
| Return on Net Operating Assets | -2.95K% |